Brannon Moncrief

In a compelling discussion, Brannon Moncrief, CEO & Principal at McLerran & Associates, shares his entrepreneurial journey in the dental M&A sector. He highlights the shift from dental finance to leading over 1,500 practice transactions. Moncrief emphasizes the need for strategic partnerships and effective delegation while navigating industry consolidation. He offers insights into balancing personal life with business growth and stresses the importance of empowering teams for sustainable success in a competitive market.

Brannon Moncrief, CEO of McLerran & Associates, dives into the critical exit mistakes that can cost dentists millions. He reveals how doctor turnover and hasty tech changes can derail sales. Brannon emphasizes the heightened interest from private equity in practices with $500k–$5M EBITDA, but warns dentistry isn’t immune to inflation. He outlines essential strategies for smart transitions and preparing practices for sale, ensuring owners aren't just surviving but thriving in a competitive market.

In this engaging discussion, Brannon Moncrief, CEO of McLerran & Associates, shares his expertise in selling dental practices. He breaks down the differences between private equity and DSO purchases, shedding light on the critical role of EBITDA in valuations. Listeners learn what makes a practice attractive to potential buyers and the vital considerations post-sale, including performance incentives. Brannon emphasizes how a strong leadership team and strategic alignment can greatly influence a practice's selling potential.

Explore the current trends of DSOs and dentistry with insights on choosing reliable partners. Learn about challenges in the DSO landscape and the impact of macroeconomic conditions. Discover strategies for monetizing a dental practice and insights on financial planning for a younger demographic.

In this podcast, they discuss the complexities of dental practice sales, comparing holdco equity with joint venture models. They explore how a practice's value can surge during a recapitalization event and the risks involved. They touch upon the benefits of joint venture models and emerging hybrid options for practice sellers.